Shasqi presented the clinical poster titled, Phase 1 Clinical Results of SQ3370, a Doxorubicin-based Click Chemistry Therapeutic in Advanced Solid Tumor Patients, on October 23, 2023 at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
